Abstract:Background: The correlations between genotype and phenotype in hypertrophic cardiomyopathy (HCM) have not been established. Mutation of alpha-actin gene (ACTC1) is a rare cause of HCM. This study aimed to explore novel genotype-phenotype correlations in HCM patients with the variants in ACTC1 and myosin binding protein (MYBPC3) genes in three unrelated Chinese families. Methods: Clinical, electrocardiographic, and echocardiographic examinations were performed in three Han pedigrees. Exon and boarding intron analysis of 96 cardio-disease-related genes was performed using second-generation sequencing on three probands. The candidate variants were validated in 14 available family members and 300 unrelated healthy controls by bi-directional Sanger sequencing. The pathogenicity and conservation were calculated using MutationTaster, PolyPhen-2, SIFT, and Clustal X. Pathogenicity classification of the variants was based on American College of Medical Genetics and Genomics (ACMG) guidelines. Results: Nine members fulfilled diagnostic criteria for HCM with clinical characteristics, electrocardiographic, and echocardiographic findings. Two candidate variants in ACTC1 p.Asp26Asn (ACTC1-D26N) and MYBPC3 p.Arg215Cys (MYBPC3-R215C) were identified in patients. Only ACTC1-D26N strongly co-segregated with the HCM phenotype. Seven patients who harbored variant ACTC-D26N only were diagnosed with non-obstructive HCM, and four of these patients exhibited a triphasic left ventricular (LV) filling pattern. Two patients carrying both ACTC1-D26N and MYBPC3-R215C variants showed a higher LV outflow tract pressure gradient. Bioinformatics analysis revealed that the two variants were deleterious and highly conserved across species. According to ACMG guidelines, ACTC1-D26N is classified as a likely pathogenic mutation. The second variation MYBPC3-R215C may function as a genetic modifier, which remains uncertain here. Conclusions: Novel p.(Asp26Asn) mutation of ACTC1 was associated with HCM phenotype, and the penetrance is extremely high (similar to 81.8%) in adults. The second variation, MYBPC3-R215C may function as a genetic modifier, which remains uncertain here. (C) 2018 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

GW24-e1791 Mutation spectrum in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy

Mutation spectrum in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy.

Characteristics of the beta myosin heavy chain gene Ala26Val mutation in a Chinese family with hypertrophic cardiomyopathy.

[Mutation and Clinical Relevance in a Large Cohort of Unrelated Chinese Patients with Hypertrophic Cardiomyopathy].

The Novel Mitochondrial 16S Rrna 2336T>C Mutation is Associated with Hypertrophic Cardiomyopathy

[Advances in the Molecular Pathogenesis of Hypertrophic Cardiomyopathy].

Preliminary Exploration of Genotype-Phenotype Correlation in Chinese with Hypertrophic Cardiomyopathy

[Analysis of MYH7, MYBPC3 and TNNT2 Gene Mutations in 10 Chinese Pedigrees with Familial Hypertrophic Cardiomyopathy and the Correlation Between Genotype and Phenotype].

[Link between cardiac myosin binding protein-C gene mutation of Pro1208fs and Gly507 Arg and hypertrophic cardiomyopathy in Chinese patients].

[Mutations in Beta Myosin Heavy Chain Gene: Two Mutations in Chinese with Familial Hypertrophic Cardiomyopathy and the Correlation Between the Genotype and Phenotype].

Echocardiographic Characterization of Hypertrophic Cardiomyopathy in Chinese Patients with Myosin-Binding Protein C3 Mutations.

Abstract 11879: the Genetic Characteristics Based on Next Generation Sequencing in Patients with Hypertrophic Cardiomyopathy

[Comparative Study of Gene Mutation Between Chinese Patients with Familial and Sporadic Hypertrophic Cardiomyopathy].

Two novel mutations of the MYBPC3 gene identified in Chinese families with hypertrophic cardiomyopathy.

Novel Phenotype–genotype Correlations of Hypertrophic Cardiomyopathy Caused by Mutation in Α-Actin and Myosin-Binding Protein Genes in Three Unrelated Chinese Families

[Novel MYBPC3 Mutations in Chinese Patients with Hypertrophic Cardiomyopathy].

Worse Prognosis With Gene Mutations Of Beta-Myosin Heavy Chain Than Myosin-Binding Protein C In Chinese Patients With Hypertrophic Cardiomyopathy

Mutation screening of cardiac myosin binding protein-C3 gene in a Chinese pedigree with familial hypertrophic cardiomyopathy

A novel mutation of the beta myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy.

Next-generation sequencing identifies pathogenic and modifier mutations in a consanguineous Chinese family with hypertrophic cardiomyopathy

Whole-exome sequencing identifies rare compound heterozygous mutations in the MYBPC3 gene associated with severe familial hypertrophic cardiomyopathy.